Papers

3

Total Citations

15

H-Index

2

About

Wei Zheng So is a pioneering surgeon-researcher at the forefront of robotic and minimally invasive surgery, with a primary focus on colorectal and urological oncology. His work centers on advancing surgical techniques to improve patient outcomes, particularly through comparative analyses of emerging robotic platforms. So’s most impactful study, a 2021 comparison of robotic low anterior resection versus transanal total mesorectal excision for rectal cancer, has garnered 8 citations and directly addresses the critical challenge of optimizing total mesorectal excision quality—a cornerstone of oncological success. He further demonstrated his technical expertise in a 2022 case series on robotic-assisted laparoscopic ureterocalicostomy for persistent uretero-pelvic junction obstruction after failed pyeloplasty, showcasing his ability to tackle complex reoperative scenarios. Most recently, in 2024, So contributed a timely overview of the Hugo RAS robotic system in urological surgery, highlighting his role as an early evaluator of next-generation surgical technology. With a growing citation footprint and a clear trajectory toward defining best practices in robotic surgery, So is establishing himself as a key voice in the evolution of minimally invasive oncologic care.

Research Focus

Key Achievements

2
H-Index
3
Papers
15
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of robotic low anterior resection <i>versus</i> transanal total mesorectal excision for rectal cancer
8 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: National University of Singapore, National University Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago